Royalty Pharma plc
US ˙ NasdaqGS ˙ GB00BMVP7Y09

SecurityRPRX / Royalty Pharma plc
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership2,681,069 shares
Latest Disclosed Value $ 128,610,880
Citadel Advisors Llc ownership in RPRX / Royalty Pharma plc

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 2,681,069 shares of Royalty Pharma plc (US:RPRX) valued at $128,610,880 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 5,273,865 shares of Royalty Pharma plc. This represents a change in shares of -49.16% during the quarter. The current value of the position is $147,378,363 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (RPRX) in the form of stock options. The firm currently holds call options representing 217,300 of underlying shares valued at $10,423,881 USD and put options representing 41,100 of underlying shares valued at $1,971,567 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RPRX / Royalty Pharma plc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 2,681,069 -2,592,796 -49.16 128,611 -36.89 0.0183
2026-02-17 2025-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 5,273,865 4,879,192 1,236.26 203,782 1,363.53 0.0306
2025-11-14 2025-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 394,673 -132,615 -25.15 13,924 -26.71 0.0021
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 527,288 -1,538,488 -74.48 18,998 -70.46 0.0033
2025-05-15 2025-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 2,065,776 -832,188 -28.72 64,308 -13.01 0.0122
2025-02-14 2024-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 2,897,964 2,897,964 73,927 0.0128
2024-08-14 2024-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 0 -97,919 -100.00 0 -100.00
2024-05-15 2024-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 97,919 -389,101 -79.89 2,974 -78.27 0.0006
2024-02-14 2023-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 487,020 363,939 295.69 13,680 309.58 0.0027
2023-11-14 2023-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 123,081 -532,291 -81.22 3,340 -83.42 0.0007
2023-08-14 2023-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 655,372 -423,582 -39.26 20,146 -48.18 0.0042
2023-05-15 2023-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,078,954 567,014 110.76 38,875 92.15 0.0085
2023-02-14 2022-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 511,940 175,979 52.38 20,232 49.87 0.0047
2022-11-14 2022-09-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 335,961 76,116 29.29 13,499 23.57 0.0031
2022-08-15 2022-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 259,845 -1,323,288 -83.59 10,924 -82.29 0.0028
2022-05-16 2022-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 1,583,133 1,371,252 647.18 61,679 630.53 0.0127
2022-02-14 2021-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 211,881 99,702 88.88 8,443 108.26 0.0017
2021-11-15 2021-09-30 13F ROYALTY PHARMA Cmn G7709Q104 112,179 -377,172 -77.08 4,054 -79.79 0.0008
2021-08-16 2021-06-30 13F ROYALTY PHARMA SHS CLASS A G7709Q104 489,351 351,746 255.62 20,058 234.19 0.0045
2021-05-21 2021-03-31 13F/A-1 ROYALTY PHARMA SHS CLASS A G7709Q104 137,605 -186,636 -57.56 6,002 -63.01 0.0015
2021-05-17 2021-03-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 137,605 -186,636 6,002 0.0015
2021-02-16 2020-12-31 13F ROYALTY PHARMA SHS CLASS A G7709Q104 324,241 256,692 380.01 16,228 471.21 0.0042
2020-11-16 2020-09-30 13F ROYALTY PHARMA SHS CL A G7709Q104 67,549 -856,056 -92.69 2,841 -93.66 0.0008
2020-08-14 2020-06-30 13F ROYALTY PHARMA Cmn G7709Q104 923,605 923,605 44,841 0.0160
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ROYALTY PHARMA SHS CLASS A Call 217,300 338.99 10,424 445.14 n/a n/a n/a
2026-02-17 2025-12-31 13F ROYALTY PHARMA SHS CLASS A Call 49,500 -70.16 1,913 -67.33 n/a n/a n/a
2025-11-14 2025-09-30 13F ROYALTY PHARMA SHS CLASS A Call 165,900 -39.05 5,853 -40.33 n/a n/a n/a
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A Call 272,200 14.51 9,807 32.54 n/a n/a n/a
2025-05-15 2025-03-31 13F ROYALTY PHARMA SHS CLASS A Call 237,700 128.34 7,400 178.68 n/a n/a n/a
2025-02-14 2024-12-31 13F ROYALTY PHARMA SHS CLASS A Call 104,100 20.91 2,656 9.03 n/a n/a n/a
2024-11-14 2024-09-30 13F ROYALTY PHARMA SHS CLASS A Call 86,100 -31.61 2,436 -26.63 n/a n/a n/a
2024-08-14 2024-06-30 13F ROYALTY PHARMA SHS CLASS A Call 125,900 54.86 3,320 34.43 n/a n/a n/a
2024-05-15 2024-03-31 13F ROYALTY PHARMA SHS CLASS A Call 81,300 56.35 2,469 69.11 n/a n/a n/a
2024-02-14 2023-12-31 13F ROYALTY PHARMA SHS CLASS A Call 52,000 -25.50 1,461 -22.91 n/a n/a n/a
2023-11-14 2023-09-30 13F ROYALTY PHARMA SHS CLASS A Call 69,800 11.32 1,894 -1.71 n/a n/a n/a
2023-08-14 2023-06-30 13F ROYALTY PHARMA SHS CLASS A Call 62,700 -23.82 1,927 -35.01 n/a n/a n/a
2023-05-15 2023-03-31 13F ROYALTY PHARMA SHS CLASS A Call 82,300 36.71 2,965 24.63 n/a n/a n/a
2023-02-14 2022-12-31 13F ROYALTY PHARMA SHS CLASS A Call 60,200 -69.32 2,379 -69.82 n/a n/a n/a
2022-11-14 2022-09-30 13F ROYALTY PHARMA SHS CLASS A Call 196,200 -21.86 7,883 -25.32 n/a n/a n/a
2022-08-15 2022-06-30 13F ROYALTY PHARMA SHS CLASS A Call 251,100 147.88 10,556 167.44 n/a n/a n/a
2022-05-16 2022-03-31 13F ROYALTY PHARMA SHS CLASS A Call 101,300 6.63 3,947 4.25 n/a n/a n/a
2022-02-14 2021-12-31 13F ROYALTY PHARMA SHS CLASS A Call 95,000 -18.17 3,786 -9.77 n/a n/a n/a
2021-11-15 2021-09-30 13F ROYALTY PHARMA Cmn Call 116,100 -12.84 4,196 -23.15 n/a n/a n/a
2021-08-16 2021-06-30 13F ROYALTY PHARMA SHS CLASS A Call 133,200 59.14 5,460 49.55 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ROYALTY PHARMA SHS CLASS A Call 83,700 16.90 3,651 1.87 n/a n/a n/a
2021-05-17 2021-03-31 13F ROYALTY PHARMA SHS CLASS A Call 83,700 3,651 n/a n/a n/a
2021-02-16 2020-12-31 13F ROYALTY PHARMA SHS CLASS A Call 71,600 189.88 3,584 244.95 n/a n/a n/a
2020-11-16 2020-09-30 13F ROYALTY PHARMA SHS CL A Call 24,700 34.97 1,039 17.00 n/a n/a n/a
2020-08-14 2020-06-30 13F ROYALTY PHARMA Cmn Call 18,300 888 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F ROYALTY PHARMA SHS CLASS A Put 41,100 10.19 1,972 36.78 n/a n/a n/a
2026-02-17 2025-12-31 13F ROYALTY PHARMA SHS CLASS A Put 37,300 103.83 1,441 123.41 n/a n/a n/a
2025-11-14 2025-09-30 13F ROYALTY PHARMA SHS CLASS A Put 18,300 -73.63 646 -74.20 n/a n/a n/a
2025-08-14 2025-06-30 13F ROYALTY PHARMA SHS CLASS A Put 69,400 4.20 2,500 20.60 n/a n/a n/a
2025-05-15 2025-03-31 13F ROYALTY PHARMA SHS CLASS A Put 66,600 30.59 2,073 59.34 n/a n/a n/a
2025-02-14 2024-12-31 13F ROYALTY PHARMA SHS CLASS A Put 51,000 283.46 1,301 246.01 n/a n/a n/a
2024-11-14 2024-09-30 13F ROYALTY PHARMA SHS CLASS A Put 13,300 -52.33 376 -48.84 n/a n/a n/a
2024-08-14 2024-06-30 13F ROYALTY PHARMA SHS CLASS A Put 27,900 -68.79 736 -72.93 n/a n/a n/a
2024-05-15 2024-03-31 13F ROYALTY PHARMA SHS CLASS A Put 89,400 -24.43 2,715 -18.30 n/a n/a n/a
2024-02-14 2023-12-31 13F ROYALTY PHARMA SHS CLASS A Put 118,300 35.82 3,323 40.63 n/a n/a n/a
2023-11-14 2023-09-30 13F ROYALTY PHARMA SHS CLASS A Put 87,100 50.69 2,364 33.05 n/a n/a n/a
2023-08-14 2023-06-30 13F ROYALTY PHARMA SHS CLASS A Put 57,800 6.84 1,777 -8.88 n/a n/a n/a
2023-05-15 2023-03-31 13F ROYALTY PHARMA SHS CLASS A Put 54,100 16.85 1,949 6.56 n/a n/a n/a
2023-02-14 2022-12-31 13F ROYALTY PHARMA SHS CLASS A Put 46,300 -29.74 1,830 -30.93 n/a n/a n/a
2022-11-14 2022-09-30 13F ROYALTY PHARMA SHS CLASS A Put 65,900 206.51 2,648 192.92 n/a n/a n/a
2022-08-15 2022-06-30 13F ROYALTY PHARMA SHS CLASS A Put 21,500 -25.09 904 -19.14 n/a n/a n/a
2022-05-16 2022-03-31 13F ROYALTY PHARMA SHS CLASS A Put 28,700 80.50 1,118 76.34 n/a n/a n/a
2022-02-14 2021-12-31 13F ROYALTY PHARMA SHS CLASS A Put 15,900 31.40 634 45.08 n/a n/a n/a
2021-11-15 2021-09-30 13F ROYALTY PHARMA Cmn Put 12,100 -78.58 437 -81.13 n/a n/a n/a
2021-08-16 2021-06-30 13F ROYALTY PHARMA SHS CLASS A Put 56,500 -41.08 2,316 -44.63 n/a n/a n/a
2021-05-21 2021-03-31 13F/A ROYALTY PHARMA SHS CLASS A Put 95,900 -50.44 4,183 -56.81 n/a n/a n/a
2021-05-17 2021-03-31 13F ROYALTY PHARMA SHS CLASS A Put 95,900 4,183 n/a n/a n/a
2021-02-16 2020-12-31 13F ROYALTY PHARMA SHS CLASS A Put 193,500 783.56 9,685 951.57 n/a n/a n/a
2020-11-16 2020-09-30 13F ROYALTY PHARMA SHS CL A Put 21,900 921 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.